Filter
274
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
15
New Publications
65
Language
Document type
No document type
112
Studies & Reports
74
Guidelines
43
Manuals
25
Strategic & Response Plan
14
Fact sheets
4
Situation Updates
2
Countries / Regions
Kenya
24
Nigeria
10
South Africa
9
Liberia
7
Ghana
7
Uganda
7
Zimbabwe
7
India
7
Ethiopia
6
Tanzania
6
Sierra Leone
5
Bangladesh
5
Western and Central Europe
5
Philippines
4
Zambia
4
Malawi
4
Botswana
4
Global
4
Senegal
3
Nepal
3
Syria
3
Rwanda
3
Ukraine
3
Eastern Europe and Central Asia
3
Cambodia
2
Indonesia
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Cameroon
1
Haiti
1
Thailand
1
Sudan
1
Brazil
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Africa
1
Eastern Europe
1
Moldova
1
North America
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
16
Pharmacy & Technologies
11
Public Health
10
Key Resources
7
Women & Child Health
5
Capacity Building
1
Toolboxes
AMR
48
Pharmacy
48
COVID-19
19
Mental Health
8
HIV
6
TB
6
Caregiver
4
NTDs
4
Malaria
4
Ebola & Marburg
3
Conflict
3
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the use of a broad range
...
First Revised Edition
March 2000
Kenya Quality Model for Health - Level 2 Facilities
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety and comparative cost-effectiveness. They are intended to be available in functioning health
...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Annex 5, WHO Technical Report Series 1010, 2018
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Accessed November 2017
